In this week’s edition of InnovationRx, we look at Summa Health’s first tech bets, the healthcare leaders on Forbes Veteran 250 list, BioMarin’s acquisition of an early-stage bone disease therapy, and more.
This week’s Current Climate newsletter also looks at big funds flowing into long-duration battery makers and the impact of a big proposed cut to NOAA’s budget.
In this week’s edition of InnovationRx, we look at the potential impact of Trump’s executive order on vaccines, the healthcare dynamos on Forbes 50 Over 50, a Swiss startup focused on a rare bleeding disorder, and more.
This week’s Current Climate newsletter also looks at who gets electricity when the grid is under strain and boom times for clean energy investment
In this week’s edition of InnovationRx, we look at Lilly’s 2Q earnings, a cannabis-derived drug for PTSD, Apnimed’s IPO and more
This week’s Current Climate newsletter also looks at Waymo’s reliance on imported Chinese EVs and a potential “super cycle” for cleantech investment.
In this week’s edition of InnovationRx, we look at Fortell’s efforts to make a better hearing aid, Abby Care’s business getting payment for caregivers, J&J’s $5.5 billion talc settlement, Scribe Therapeutics’ IPO, and more.
This week’s Current Climate newsletter also looks at why Tesla’s founders are backing an anti-Cybertruck and Sila’s expanding production of silicon battery anodes.
In this week’s edition of InnovationRx, we look at the companies looking to cash in on the coming peptide bonanza, the ongoing cyclosporiasis outbreak, Tempus’s acquisition of a cancer-testing company, and more.
This week’s Current Climate newsletter also looks at how the U.S. EV market is about to get quirkier and the bipartisan appeal of recycling.